BORVIZ BORTEZOMIB INJECTION

Get a Price/Quote

BORVIZ BORTEZOMIB INJECTION Specification

Origin of Medicine
Imported

Salt Composition
Bortezomib 2 mg

Dosage Form
Injection

Indication
Treatment of multiple myeloma and mantle cell lymphoma

Pacakaging (Quantity Per Box)
1 vial per box

Drug Type
Prescription Drug

Ingredients
Bortezomib

Physical Form
Liquid Injection

Function
Anti-cancer (Antineoplastic)

Recommended For
Multiple Myeloma, Mantle Cell Lymphoma

Dosage
As directed by physician

Dosage Guidelines
Intravenous or subcutaneous administration

Suitable For
Adults

Quantity
1 vial

Storage Instructions
Store below 25C, protect from light

BORVIZ BORTEZOMIB INJECTION Trade Information

Packaging Details
PACK OF 1 VIAL

Main Domestic Market
All India

About BORVIZ BORTEZOMIB INJECTION

Borviz 2mg Injection

Specifications :-

Brand Name :- BORVIZ
Content:- Bortezomib
Strength:- 2 Mg
Form:- Injection
Packing:- Pack of 1 vial
Manufactured By :- INTAS

Note :- BORVIZ Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug.............

Powerful Anti-Cancer Action

Borviz Bortezomib Injection is specifically designed to target multiple myeloma and mantle cell lymphoma, inhibiting cancer cell growth with precision. As an antineoplastic agent, its mechanism of action involves disrupting cancerous cells life cycle, making it an essential part of modern oncological treatment.

Flexible Administration Routes

Borviz offers flexibility in administration, allowing for intravenous or subcutaneous injection based on patient needs. This versatility accommodates individualized clinical scenarios, enhancing comfort and convenience during therapy. Administration is always performed under medical supervision.

Safety and Handling Precautions

As a cytotoxic medication, Borviz requires careful handling to minimize exposure risks. Healthcare professionals adhere to strict protocols when preparing and administering the injection. It is important to follow all safety guidelines and use personal protective equipment when managing this hazardous drug.

FAQs of BORVIZ BORTEZOMIB INJECTION:

Q: How should Borviz Bortezomib Injection be administered?

A: Borviz should be administered by a qualified healthcare professional using either the intravenous (IV) or subcutaneous (SC) route, depending on the patients treatment plan as prescribed by the physician.

Q: What conditions is Borviz prescribed to treat?

A: This injection is indicated for the treatment of adults diagnosed with multiple myeloma and mantle cell lymphoma. It must be used under medical supervision and with an appropriate prescription.

Q: Where should Borviz Bortezomib Injection be stored and how can its shelf life be maintained?

A: Borviz must be stored below 25C and protected from light to maintain its potency throughout its 24-month shelf life. Always keep it in its original packaging until use.

Q: What precautions should be taken when handling Borviz?

A: As Borviz is a cytotoxic medication, it should be handled with gloves and other protective gear to avoid exposure. Preparation and administration must follow established safety procedures to ensure safe use.

Q: What is the benefit of receiving Borviz Bortezomib Injection?

A: Borviz offers effective anti-cancer benefits for patients with multiple myeloma and mantle cell lymphoma, helping to control disease progression and improve treatment outcomes under the guidance of an oncologist.

Q: Who can use Borviz Bortezomib Injection?

A: This medication is suitable for adult patients and is not recommended for children. The exact dosage and administration are determined by a healthcare provider based on individual needs.

Tell us about your requirement